Protagonist Therapeutics, Inc Increase in Carrying Amount of Redeemable Preferred Stock
Protagonist Therapeutics, Inc (PTGX) reported Increase in Carrying Amount of Redeemable Preferred Stock of $558.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-07.
Discontinued › Shareholders' Equity
us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock · last filed 2017-03-07
- Protagonist Therapeutics, Inc increase in carrying amount of redeemable preferred stock for fiscal 2016 was $558.00K, a 644.00% increase from fiscal 2015.
- Protagonist Therapeutics, Inc increase in carrying amount of redeemable preferred stock for fiscal 2015 was $75.00K, a 48.63% decline from fiscal 2014.
- Protagonist Therapeutics, Inc increase in carrying amount of redeemable preferred stock for fiscal 2014 was $146.00K.
| Period end | Increase in Carrying Amount of Redeemable Preferred Stock 12 month |
|---|---|
| 2016-12-31 | $558.00K 10-K · filed 2017-03-07 |
| 2015-12-31 | $75.00K 10-K · filed 2017-03-07 |
| 2014-12-31 | $146.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |